U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
Lactose is the most important carbohydrate in the milk of most species. Its biosynthesis takes place in the mammary gland. The molecular structures of α- and β -lactose differ in the orientation of a hydrogen- and a hydroxyl group on carbon atom no.1 in the glucose moiety. Both forms change into one another continuously. At room temperature, the equilibrium results in a ratio of about 40% α-lactose and 60% β-lactose. The fact that two forms of lactose exist which differ in molecular structure has profound effects on various properties of lactose such as crystallization behavior, crystal morphology, solid-state properties, and solubility. The intestine does not actively absorb lactose unless it is split into its two-monosaccharide components, i.e. glucose and galactose. This hydrolysis of lactose is affected by the enzyme lactase, which is produced by the epithelium cells in the brush-border of the small intestine. Thus, the capacity of mammals to digest lactose is dependent on the lactase activity in the intestine. The maximum activity of the enzyme occurs shortly after birth and declines during the weaning period, after which it remains at a relatively constant level. Genetically determined factors governing residual lactase activity also exist. Individuals having low lactase activity are called lactose malabsorbers. Lactose intolerance is a condition in which people have symptoms due to the decreased ability to digest lactose. The principal symptom of lactose intolerance is an adverse reaction to products containing lactose (primarily milk), including abdominal bloating and cramps, flatulence, diarrhea, nausea, borborygmi, and vomiting (particularly in adolescents). These appear one-half to two hours after consumption.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P09848
Gene ID: 3938.0
Gene Symbol: LCT
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Identification and synthesis of a novel 15 kDa beta-galactoside-binding lectin in human leukocytes.
1992 Aug
The use of lactose recrystallised from carbopol gels as a carrier for aerosolised salbutamol sulphate.
2001 Jan
The bulk crystallization of alpha-lactose monohydrate from aqueous solution.
2001 Jul
Characterisation and disintegration properties of irradiated starch.
2001 Jun 19
Determination of indomethacin crystallinity in the presence of excipients using diffuse reflectance near-infrared spectroscopy.
2001 Nov
Effect of carrier excipient and processing on stability of indorenate hydrochloride/excipient mixtures.
2001 Nov
Role of galectin-3 in adenocarcinoma liver metastasis.
2001 Nov
Quantifying electrostatic interactions in pharmaceutical solid systems.
2001 Oct 4
Generation of live rat offspring by intrauterine insemination with epididymal spermatozoa cryopreserved at -196 degrees C.
2001 Sep
Effect of lacZY-marking of the 2,4-diacetyl-phloroglucinol producing Pseudomonas fluorescens-strain 5-2/4 on its physiological performance and root colonization ability.
2002
Scaling-up of a lactose wet granulation process in Mi-Pro high shear mixers.
2002 Dec
Dry powder inhaler: influence of humidity on topology and adhesion studied by AFM.
2002 Jan 31
Continuous twin screw extrusion for the wet granulation of lactose.
2002 Jun 4
Investigation of excipient type and level on drug release from controlled release tablets containing HPMC.
2002 May
Wax beads as cushioning agents during the compression of coated diltiazem pellets.
2002 Nov
Synthesis and anti-HCMV activity of novel acyclic nucleosides.
2002 Oct
The in vitro dissolution of theophylline from different types of hard shell capsules.
2002 Oct
A recombinant Saccharomyces cerevisiae strain for efficient conversion of lactose in salted and unsalted cheese whey into ethanol.
2002 Oct
Characterization of a surface modified dry powder inhalation carrier prepared by "particle smoothing".
2002 Oct
Purification and physicochemical characterization of a cotyledonary lectin from Luetzelburgia auriculata.
2002 Oct
The evaluation of the rheological properties of lactose/microcrystalline cellulose and water mixtures by controlled stress rheometry and the relationship to the production of spherical pellets by extrusion/spheronization.
2002 Oct
Predicting the quality of powders for inhalation from surface energy and area.
2002 Sep
Lactose modifications enhance its drug performance in the novel multiple dose Taifun DPI.
2002 Sep
Development of agglomerated directly compressible diluent consisting of brittle and ductile materials.
2003
Formulation design of carbamazepine fast-release tablets prepared by melt granulation technique.
2003 Apr 30
Quantitative determination of crystallinity of alpha-lactose monohydrate by Near Infrared Spectroscopy (NIRS).
2003 Apr 30
Influence of inverse gas chromatography measurement conditions on surface energy parameters of lactose monohydrate.
2003 Apr 30
Synthesis of novel apionucleosides: a short and concise synthesis of 2-deoxyapio-L-furanosyl acetate from D-lactose.
2003 Apr 4
Studies on the preparation of chitosan microcarriers cross-linked by oxidized lactose and culture of primary hepatocytes.
2003 Aug
In vitro nutritional requirements and metabolic products of pathogenic and nonpathogenic strains of Cryptobia salmositica: essential carbohydrates and amino acids.
2003 Aug 15
Determining the compression behaviour of pharmaceutical powders from the force-distance compression profile.
2003 Feb 18
Further investigations into the use of high sensitivity differential scanning calorimetry as a means of predicting drug-excipient interactions.
2003 Feb 18
Influence of physico-chemical carrier properties on the in vitro aerosol deposition from interactive mixtures.
2003 Feb 18
Carotenoid production by lactoso-negative yeasts co-cultivated with lactic acid bacteria in whey ultrafiltrate.
2003 Jul-Aug
The preparation of agglomerates containing solid dispersions of diazepam by melt agglomeration in a high shear mixer.
2003 Jun 18
Staphylococcus equorum subsp. linens, subsp. nov., a starter culture component for surface ripened semi-hard cheeses.
2003 Mar
Effects of excipients on hydrate formation in wet masses containing theophylline.
2003 Mar
Effect of aeration on the production of carotenoid pigments by Rhodotorula rubra-lactobacillus casei subsp. casei co-cultures in whey ultrafiltrate.
2003 Mar-Apr
Nutritional requirements of Pochonia chlamydospora and ARF18, fungal parasites of nematode eggs.
2003 May
The influence of carrier and drug morphology on drug delivery from dry powder formulations.
2003 May 12
The relationship between granule growth mechanism, amount of liquid binder added and properties of the wet powder mass determined using a split bed shear tester.
2003 May 12
Physiological studies of Escherichia coli strain MG1655: growth defects and apparent cross-regulation of gene expression.
2003 Sep
Synthesis and hemolytic activity of some hederagenin diglycosides.
2004 Aug
Single-step granulation/tabletting of different grades of lactose: a comparison with high shear granulation and compression.
2004 Jul
Quantifying low amorphous or crystalline amounts of alpha-lactose-monohydrate using X-ray powder diffraction, near-infrared spectroscopy, and differential scanning calorimetry.
2004 May
Aerosolisation of beclomethasone dipropionate using spray dried lactose/polyethylene glycol carriers.
2004 Nov
Compaction of crystallographic forms of pharmaceutical granular lactoses. II. Compacts mechanical properties.
2004 Nov
Approaches to determine the enthalpy of crystallisation, and amorphous content, of lactose from isothermal calorimetric data.
2004 Oct 13
Blockage of Galectin-receptor Interactions by α-lactose Exacerbates Plasmodium berghei-induced Pulmonary Immunopathology.
2016 Aug 24
Lactase Non-persistence and Lactose Intolerance.
2017 May

Sample Use Guides

presence lactose in the food
Route of Administration: Oral
In Vitro Use Guide
There was evaluated the capability of colonic bacteria to ferment lactose and the ability of L. acidophilus to modify lactose fermentation by the colonic microflora in vitro. An anaerobic continuous culture was established and inoculated with fresh samples of human feces. Lactose infusion was maintained at 25 g/d and pH at 6.7. L. acidophilus strain LA-1 (1.5 x 10(10) cells) was introduced into the fermenter on d 0 or added daily on d 0 through 4. The control was the continuous culture without the addition of lactobacilli. Rapid adaptation of colonic bacteria to lactose occurred within 1-2 d, with a significant decrease in lactose concentration and increase in beta-galactosidase activity, and lactose concentrations fell below 3 mmol/L by d 7.
Substance Class Mixture
Created
by admin
on Fri Dec 15 16:38:58 GMT 2023
Edited
by admin
on Fri Dec 15 16:38:58 GMT 2023
Record UNII
J2B2A4N98G
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LACTOSE, UNSPECIFIED FORM
Common Name English
SACCHARUM LACTIS
HPUS  
Common Name English
LACTOSE [EP MONOGRAPH]
Common Name English
LACTOSE [VANDF]
Common Name English
LACTOSE [INCI]
Common Name English
LACTOSE
II   INCI   VANDF   WHO-DD  
INCI  
Official Name English
LACTOSE-ELECTRICITAS
Common Name English
SACCHARUM LACTIS [HPUS]
Common Name English
LACTOSE [II]
Common Name English
Lactose [WHO-DD]
Common Name English
MILK SUGAR
Common Name English
Classification Tree Code System Code
LOINC 2553-6
Created by admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
LOINC 17043-1
Created by admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
CFR 21 CFR 168.122
Created by admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
LOINC 2554-4
Created by admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
NCI_THESAURUS C68472
Created by admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
DSLD 1133 (Number of products:14)
Created by admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
LOINC 74438-3
Created by admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
LOINC 51598-1
Created by admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
LOINC 2552-8
Created by admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
Code System Code Type Description
NCI_THESAURUS
C28166
Created by admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
PRIMARY
WIKIPEDIA
LACTOSE
Created by admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
PRIMARY
ChEMBL
CHEMBL417016
Created by admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
PRIMARY
CHEBI
36218
Created by admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
PRIMARY
CHEBI
17716
Created by admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
PRIMARY
MESH
D007785
Created by admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
PRIMARY
CHEBI
36219
Created by admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
PRIMARY
RXCUI
6211
Created by admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
PRIMARY RxNorm
FDA UNII
J2B2A4N98G
Created by admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
PRIMARY
DAILYMED
J2B2A4N98G
Created by admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
PRIMARY
DRUG BANK
DB04465
Created by admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
PRIMARY
DRUG CENTRAL
1535
Created by admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
PRIMARY
EVMPD
SUB14317MIG
Created by admin on Fri Dec 15 16:38:58 GMT 2023 , Edited by admin on Fri Dec 15 16:38:58 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY
Definition References